Scientific Papers

This study presents a pioneering evaluation of QS-18, an abundant fraction from Quillaja saponaria, as a vaccine adjuvant within liposomal formulations for seasonal influenza. Traditionally, [...]

This paper provides a comprehensive analysis of the global supply chain for Quillaja-derived saponin adjuvants, notably QS-21, which are pivotal components in several recent and upcoming vaccines [...]

This original paper from Desert King provides a comprehensive evaluation of the scalability, sustainability, and supply capacity of QS-21, a highly potent saponin adjuvant derived from Quillaja [...]

The saponin QS-21, derived from Quillaja saponaria, has been clinically successful in vaccines due to its ability to elicit robust humoral and cellular immunity, exemplified by its inclusion in [...]

This research addresses the critical need to improve vaccine adjuvants, which are essential for enhancing immune responses in subunit vaccines. While AS01 has demonstrated potent [...]

 Malaria remains a major global health challenge, particularly in endemic regions where effective vaccines are critically needed. Recent advances include the development of vaccines targeting [...]

 This paper emphasizes the growing global burden of dementia, particularly Alzheimer's disease, which is predicted to nearly double by 2050 due to aging populations worldwide. It [...]

 This study focuses on QS-21, a potent saponin adjuvant essential for human vaccines, traditionally sourced from the bark of mature Quillaja saponaria trees in Chile. The researchers identified a [...]

 The Quillaja saponaria tree, native to central Chile, has historically been valued for its soap-like bark containing saponins, which produce foam and have traditional cleaning uses. Its [...]

The paper explores how various adjuvants influence the immune response and hematopoietic pathways, particularly focusing on megakaryocytes and platelets, which are emerging as key players in [...]